Drial Consultants, Inc.
United StatesFDA 510(k) applicant, unverified
- Devices
- 13
What Drial Consultants, Inc. makes
Drial Consultants, Inc. manufactures rapid, single-step urine drug testing devices for detecting cocaine, benzodiazepines, methamphetamine, opiates, amphetamines, barbiturates, and THC (marijuana). The portfolio includes both cassette-style (QUIKSTRIP) and pouch-style (QUIKPAC II) formats designed for point-of-care use.
All listed devices fall under Class II regulation in the US, with each authorised via the FDA 510(k) clearance process. The company’s products are registered with the FDA under this framework, ensuring compliance with drug testing standards for clinical and non-clinical applications.
Catalogue
Search and filter all 13 devicesFrequently asked questions
How many devices does Drial Consultants, Inc. have in the registry?
The registry currently lists 13 devices for Drial Consultants, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Drial Consultants, Inc.'s devices?
Among its 13 most recently registered devices, Drial Consultants, Inc. has devices listed in FDA 510(k) (13 devices).
What risk classes do Drial Consultants, Inc.'s devices fall under?
Among its 13 most recently registered devices, the classes recorded for Drial Consultants, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Drial Consultants, Inc. in the registry?
The most recently registered devices listed for Drial Consultants, Inc. include QUIKPAC II ONE STEP COCAINE TEST, QUIKSTRIP ONE STEP COCAINE TEST, QUIKPAC II ONE STEP BENZODIAZEPINE TEST and QUIKSTRIP ONE STEP BENZODIAZEPINE TEST.